Nolato AB (publ)
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more
Market Cap & Net Worth: Nolato AB (publ) (NLTBF)
Nolato AB (publ) (PINK:NLTBF) has a market capitalization of $1.27 Billion ($1.27 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #7801 globally and #4066 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nolato AB (publ)'s stock price $5.27 by its total outstanding shares 241783080 (241.78 Million).
Nolato AB (publ) Market Cap History: 2015 to 2025
Nolato AB (publ)'s market capitalization history from 2015 to 2025. Data shows growth from $83.34 Million to $1.27 Billion (33.39% CAGR).
Nolato AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nolato AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.13x
Nolato AB (publ)'s market cap is 0.13 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.94x
Nolato AB (publ)'s market cap is 1.94 times its annual earnings
1.97x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $83.34 Million | $4.73 Billion | $420.00 Million | 0.02x | 0.20x |
| 2016 | $149.40 Million | $4.45 Billion | $336.00 Million | 0.03x | 0.44x |
| 2017 | $157.64 Million | $6.72 Billion | $572.00 Million | 0.02x | 0.28x |
| 2018 | $168.52 Million | $8.10 Billion | $722.00 Million | 0.02x | 0.23x |
| 2019 | $168.52 Million | $7.92 Billion | $703.00 Million | 0.02x | 0.24x |
| 2020 | $650.06 Million | $9.36 Billion | $806.00 Million | 0.07x | 0.81x |
| 2021 | $796.05 Million | $11.61 Billion | $1.16 Billion | 0.07x | 0.69x |
| 2022 | $732.09 Million | $10.77 Billion | $697.00 Million | 0.07x | 1.05x |
| 2023 | $922.40 Million | $9.55 Billion | $435.00 Million | 0.10x | 2.12x |
| 2024 | $1.27 Billion | $9.66 Billion | $658.00 Million | 0.13x | 1.94x |
Competitor Companies of NLTBF by Market Capitalization
Companies near Nolato AB (publ) in the global market cap rankings as of March 18, 2026.
Key companies related to Nolato AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Nolato AB (publ) Historical Marketcap From 2015 to 2025
Between 2015 and today, Nolato AB (publ)'s market cap moved from $83.34 Million to $ 1.27 Billion, with a yearly change of 33.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.27 Billion | 0.00% |
| 2024 | $1.27 Billion | +38.15% |
| 2023 | $922.40 Million | +25.99% |
| 2022 | $732.09 Million | -8.03% |
| 2021 | $796.05 Million | +22.46% |
| 2020 | $650.06 Million | +285.74% |
| 2019 | $168.52 Million | 0.00% |
| 2018 | $168.52 Million | +6.90% |
| 2017 | $157.64 Million | +5.52% |
| 2016 | $149.40 Million | +79.26% |
| 2015 | $83.34 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Nolato AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.27 Billion USD |
| MoneyControl | $1.27 Billion USD |
| MarketWatch | $1.27 Billion USD |
| marketcap.company | $1.27 Billion USD |
| Reuters | $1.27 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.